The Chemours Company

The Chemours Company (CC) Market Cap

The Chemours Company has a market capitalization of .

No quote data available.

CEO: Denise Dignam

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 2015-06-19

Website: https://www.chemours.com

The Chemours Company (CC) - Company Information

Market Cap: -|Sector: Basic Materials

Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Analyst Sentiment

70%
Buy

From 9 Active Polls

1Y Forecast: $25.75

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$30

High Bound

$30

Average

$26

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$25.75
▲ +25.61% Upside
Low Target
$17.00
-17% Risk
Median Target
$29.50
44% Mid
High Target
$30.00
46% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CHEMOURS (CC) — Investment Overview

🧩 Business Model Overview

Chemours is a specialty chemicals manufacturer with a portfolio concentrated in high-performance materials and regulated chemicals. The business model is built around producing chemically engineered inputs that downstream customers incorporate into coatings, plastics, industrial applications, and refrigeration systems.

Value creation flows from (1) proprietary or qualified formulations and production processes, (2) reliable operation of chemical plants with significant process know-how, and (3) customer qualification pathways that favor incumbent suppliers for performance-critical specifications and compliance requirements. Sales are largely project and volume driven, with profitability influenced by industry capacity discipline, operating efficiency, and the ability to manage raw-material and energy costs.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly transactional (not subscription-like), derived from volumes sold into end markets. The monetisation model relies on achieving attractive product “spreads” versus key cost inputs and on maintaining high utilization of fixed assets.

  • Seasonal/price-cycle exposure: Product pricing and realizations typically move with global supply-demand balance for titanium dioxide (TiO₂) pigments and specialty fluorochemicals/refrigerant-related materials.
  • Margin drivers: Manufacturing cost position (energy, feedstocks, labor, maintenance), conversion efficiency/yield, and stable plant operations. For regulated refrigerants and specialty blends, margin can also reflect the ability to supply compliant alternatives that meet technical and regulatory requirements.
  • Mix and qualification benefits: Specialty grades and applications with higher performance requirements tend to support more resilient margins than commodity-like offerings, though the cycle still matters.

🧠 Competitive Advantages & Market Positioning

Chemours competes in markets where performance specifications, compliance obligations, and manufacturing know-how create practical barriers to entry. The core moat is a combination of customer qualification/switching frictions and regulatory-driven product positioning, supported by an established cost base in energy-intensive chemical production.

  • Switching costs (practical, not contractual): For specialty fluorochemical materials and performance-oriented TiO₂ applications, customers incur engineering testing, qualification, and sometimes formulation rework. Once specifications are validated, re-sourcing carries technical and compliance risk, which favors incumbents.
  • Regulatory positioning: Refrigerants and related chemical systems operate under ongoing global regulatory phase-down and labeling rules. Suppliers with compliant, technically validated product portfolios are advantaged when customers must reformulate or replace legacy chemistries.
  • Cost and operating discipline: Chemical manufacturing benefits from operational excellence, scale, and reliable supply. Competitors with weaker cost structures or less integrated supply chains can be pressured during downturns, improving the relative position of firms like Chemours with disciplined execution.

Competitive benchmarking:

  • Tronox (primarily TiO₂ pigments): Focuses more narrowly on TiO₂, making its profitability more directly tied to pigment cycle dynamics. Chemours maintains exposure across a broader set of specialty chemicals, which can diversify end-market timing.
  • Venator (primarily TiO₂ pigments): Similar to Tronox in being largely concentrated in TiO₂, with cost position and capacity utilization central to outcomes. Chemours’ specialty/regulatory exposure can change the way it experiences demand shifts.
  • DuPont (broader specialty materials including fluorochemicals and high-performance products): DuPont’s scale and breadth span multiple specialty platforms. Chemours competes as a focused manufacturer with depth in regulated and performance chemical systems, where product qualification and supply reliability can matter as much as breadth.

🚀 Multi-Year Growth Drivers

  • Environmental and regulatory-driven chemical substitution: Continued global refrigerant transition and compliance requirements support demand for chemistries that meet low-GWP and performance constraints.
  • Coatings and plastics demand intensity: TiO₂ remains embedded in durable coatings and plastics where color, opacity, and performance matter. Longer-run growth in construction, mobility, and industrial manufacturing supports addressable demand.
  • Efficiency and performance requirements: Industrial customers increasingly specify materials that improve energy efficiency, durability, and end-use performance. Chemours’ specialty portfolio can benefit when customer requirements move away from “lowest cost” toward “best qualified performance.”
  • Capacity discipline and geographic supply reliability: Specialty chemical markets often reward suppliers that can deliver stable supply quality. Well-operated capacity can strengthen share during periods of industry maintenance or disruption.

Over a 5–10 year horizon, the TAM outlook is less about outright market “growth” and more about structural share shifts: compliant refrigerants, performance-driven formulations, and suppliers with the operational capability to meet qualification requirements.

⚠ Risk Factors to Monitor

  • Regulatory and compliance risk: Refrigerant regulations can tighten or change with policy cycles. Product approvals, customer substitution timelines, and end-use restrictions can affect volumes and pricing.
  • Environmental liabilities and permitting: Chemical production carries ongoing environmental exposure (emissions, waste handling, remediation). Changes in standards can increase operating costs or require capital spending.
  • Commodity and capacity cycle sensitivity: TiO₂ and portions of specialty chemicals remain exposed to industry overcapacity, utilization swings, and raw-material/energy volatility.
  • Technological substitution risk: Alternative chemistries or process innovations can alter competitive dynamics, particularly in segments tied to refrigerant system engineering.
  • Capital intensity and execution risk: Plant reliability, turnarounds, and compliance-driven upgrades require consistent capital allocation and operational execution.

📊 Valuation & Market View

Market valuation for specialty chemicals like Chemours typically centers on enterprise value relative to operating earnings (commonly EV/EBITDA) and assessments of cycle-adjusted profitability. Because earnings are influenced by pricing/spreads and utilization, investors tend to focus on:

  • Operating margin durability: Cost position, yield improvement, and ability to sustain favorable product mix.
  • Leverage and balance-sheet flexibility: A chemicals cycle can pressure cash generation; valuation discounts often follow rising leverage or reduced flexibility.
  • Working-capital behavior: Inventory and pass-through dynamics can swing cash flow even when reported earnings appear stable.
  • Investment requirements: Environmental compliance and capacity maintenance can affect free cash flow through the cycle.

In this sector, valuation “moving parts” are less about growth rate multiples and more about credible paths to normalized margins and disciplined capital allocation.

🔍 Investment Takeaway

Chemours offers a specialty-chemicals exposure where competitiveness is driven by qualification-driven switching friction, regulatory-aligned product positioning, and manufacturing cost/operating discipline. The investment thesis is that sustained operational execution plus compliant product supply can support cycle-adjusted earnings power, while risks remain concentrated in environmental/regulatory outcomes and the underlying commodity-style profitability of key product markets.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q1): Revenue $1.381B, EPS -$0.19, Net Income -$29.0M (net margin -2.1%). QoQ (vs 2025-12-31): Revenue rose +3.9% (from $1.330B). Net loss narrowed from -$61.0M to -$29.0M (improvement of +$32.0M). Gross margin expanded from 11.5% to 15.4% (+3.9pp), and operating income swung slightly positive to +$39M (vs -$259M), indicating improving cost structure despite still-heavy interest and other items. YoY (vs 2025-03-31): Revenue increased +0.9% (from $1.368B). Net income deteriorated meaningfully: -$29.0M vs -$4.0M (about -$25.0M worse), with margins contracting from near breakeven/low losses to a wider negative outcome. Cash flow: operating cash flow is reported as $0 in Q1, with free cash flow also -$49M driven by capex/dividends timing. Dividends paid were -$13M; balance sheet liquidity remains solid with $563M cash and net debt improving to -$334M (net cash). Total shareholder return: stock price is $23.18 and up +110.3% over 1 year, a strong momentum tailwind. However, profitability remains volatile with negative earnings, limiting fundamental support for the run-up."

Revenue Growth

Neutral

QoQ revenue +3.9% (1.330B to 1.381B). YoY revenue +0.9% (1.368B to 1.381B), indicating low growth with recent sequential improvement.

Profitability

Neutral

Net margin remains negative at -2.1% in Q1. QoQ operating income improved (from -$259M to +$39M) and gross margin expanded (11.5% to 15.4%), but YoY net income worsened (-$29M vs -$4M). EPS is still -$0.19.

Cash Flow Quality

Caution

Operating cash flow is shown as $0 in Q1 with free cash flow -$49M, alongside -$13M dividends paid. Prior quarters generated positive operating cash flow, but Q1 reporting/timing weakens cash conversion.

Leverage & Balance Sheet

Positive

Liquidity is strong: cash $563M. Net debt improved to -$334M (net cash) vs +$3.92B net debt a year earlier, though equity is much lower than prior-year figures (Q1 equity ~$216M vs ~$580M in Q1’25), suggesting structural balance-sheet pressure.

Shareholder Returns

Strong

Price momentum is very strong: +110.3% 1y. Dividend yield is small (~0.0% from provided ratios), and buybacks are not evidenced in the cash flow, but total return is likely dominated by capital appreciation.

Analyst Sentiment & Valuation

Neutral

Consensus price target $22.14 vs current $23.18 implies modestly below-current valuation. High variance in targets (high $30 / low $17) suggests uncertainty consistent with volatile earnings.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Chemours started 2026 with a strong Q1 led by TSS and TT, while APM remained constrained by discrete disruptions. TSS delivered record results with net sales +22% YoY and adjusted EBITDA margin expanding to 33%, supported by Freon/Opteon pricing and mix despite R-32 cost offsets. TT exceeded expectations through global pricing actions and cost discipline even as non-western volumes/mix pressured growth. APM’s Q1 reflected Washington Works outage and SPS Capstone line closure, producing a $25M adjusted EBITDA headwind and keeping earnings in low levels into Q2, although management emphasized improved order velocity and strong semiconductor/data center demand. Guidance is detailed and back-half weighted: Q2 consolidated net sales up 15%–20% sequentially with adjusted EBITDA of $220M–$250M, while TSS and TT show margin support via pricing and cost-out. Key risks are residential cooling-season weakness, water emergency curtailment risk, and geopolitical-driven cost and demand volatility.

AI IconGrowth Catalysts

  • TSS record Q1: double-digit YoY growth in up-down refrigerants (Freon and Opteon), driven by higher pricing, stronger volume growth, and favorable product mix
  • Opteon transition momentum and quota execution: additional opportunities captured in on refrigerants via disciplined quota management and agile commercial execution
  • TT exceeded earnings expectations: global pricing actions plus strong cost management and operational focus supported results despite volume/mix pressure in non-western markets
  • APM order strength offset by operational disruptions: Performance Solutions order book strength in semiconductor and data center end markets despite Washington Works outage and prior closure of SPS Capstone line
  • Operational reliability improvement: pricing actions (December and April 1) coupled with progress in reliability to support responsiveness to demand shifts

Business Development

  • Signed a long-term chlorine supply contract with an unspecified counterparty to service the DeLisle site starting in 2028 (value-accretive economics; ensures reliable supply)
  • Planned on-site Corning facility at DeLisle (previously intended with a third party) terminated due to termination of an on-site supply agreement in March; company will not proceed
  • Completed sale of nearly all Kuan Yin properties ahead of schedule; remaining land parcel planned for completion in 2026 (incremental $60M gross proceeds referenced)
  • Refinancing completed in March: $700M refinancing of 2027 unsecured notes and portion of 2028 unsecured notes extending maturities to 2034

AI IconFinancial Highlights

  • Q1 overall: adjusted performance “well above earnings expectations” (no numeric EPS provided in transcript)
  • TSS net sales +22% YoY; sequential net sales +28% (seasonal ramp)
  • TSS adjusted EBITDA margin expanded to 33% (offset by higher input costs, particularly R-32)
  • TT adjusted EBITDA exceeded expectations (specific Q1 range not provided); driven by pricing actions and strong cost management; lower volumes and less favorable non-western product mix reduced global volumes
  • APM net sales down YoY; adjusted EBITDA headwind $25M due to Washington Works outage and SPS Capstone line closure impact on sales and incremental costs
  • Pricing up ~3% sequentially in Q1 (initial impact from December and ongoing April 1 price changes communicated across key end markets)

AI IconCapital Funding

  • Q2 free cash flow generation: at least $100M; capex expected $50M in Q2
  • Q2 interest expense savings: reduced debt by approximately $160M in connection with strong free cash flow outlook
  • Total near-term debt addressed since Q4 2025: close to $2B (per management); $700M refinancing completed in March
  • Full-year: plans to pay down approximately $150M of outstanding Euro Term Loan B (timing tied to land sale proceeds)
  • Liquidity objective: net leverage below 3x adjusted EBITDA; 2026 year-end net leverage expected below 3.8x adjusted EBITDA

AI IconStrategy & Ops

  • Chemours Business System (CBS) integration and lean principles: already observing positive outcomes after CBS implementation earlier in 2026
  • Manufacturing flexibility: modifying production levels to meet shifting demand; operational circuit enhancements to improve visibility and reliability for TT
  • APM cost/volume constraints: Washington Works downtime continuing to weigh on profitability into Q2 despite resumption of normal operations expected for sequential sales improvement
  • Residential demand caution: management attributes softer residential OEM/aftermarket to slower start to the reference cooling season and decelerated distribution networks

AI IconMarket Outlook

  • TSS Q2 net sales: low to mid-teens sequential % increase; adjusted EBITDA for PFS expected $210M–$225M sequentially
  • TSS Q2 constraint noted: $10M adjusted EBITDA demand impact pulled into Q1 (timing modestly tempers sequential progression)
  • TT Q2 adjusted EBITDA expected $40M–$50M; no volume upside built into outlook; improvement expected via pricing and cost-out
  • APM Q2 net sales: low to high 30% sequential % increase; adjusted EBITDA $12M–$18M
  • Consolidated Q2 net sales: 15%–20% sequential increase; consolidated adjusted EBITDA $220M–$250M
  • Corporate expenses in Q2: $45M–$50M
  • Full-year consolidated guidance unchanged: net sales, adjusted EBITDA, and capex align with prior guidance; full-year free cash flow conversion now expected above 20% but slightly lower than prior guidance due to one-off land sale tax implications
  • Full-year 2026 growth narrative: confidence in step-up performance in second half to deliver on full-year guide (no updated consolidated EPS provided)

AI IconRisks & Headwinds

  • APM: earnings constrained by Washington Works outage effects and prior closure of APM SPS Capstone line; Q1 adjusted EBITDA headwind $25M and Q2 profitability in low targeted levels
  • TSS: weaker residential demand (slower start to reference cooling season; decelerated equipment/aftermarket leading indicator via distribution networks); management explicitly “cautious” on residential demand segments
  • Geopolitics: ongoing Middle East conflict and energy market volatility potentially weighing on demand in impacted regions; worldwide TiO2 market impacts cited
  • Supply chain/utility risk: potential Level 1 water emergency in Corpus Christi—management cited potential 25% curtailment potentially announced for Q4 already dialed into outlook; reliance on alternative partners highlighted
  • Raw material cost inflation: higher input costs including R-32 for TSS; sulfur-market tightening driving cost inflation for TiO2 sulfate producers; competition/pricing aggressiveness risk in international markets
  • Geopolitical outcomes uncertain for TT and related market demand; visibility improved but remains exposed

Q&A: Analyst Interest

  • TSS Freon auto aftermarket contribution and “stickiness”: Management said Freon auto aftermarket strength was more about optimized EBITDA per quota and a uniquely positioned supply position (1 of 2 domestic suppliers of 134a). They also cited EPA regulated phasedown constraints on other suppliers, plus expectations set before the quarter, though realized upside exceeded initial anticipation.
  • APM sustainable earnings power post-outage and ramp timing: Management guided APM to a $30M–$40M EBITDA range and stated they “definitely” expect recovery into the back half of the year. They tied the timing to the Performance Solutions portfolio’s strong semiconductor and data center order book and improving order velocity.
  • TiO2 sulfur-cost impact playbook (pricing vs volumes) and global response: Management reiterated a low-cost chloride producer strategy and “gaining share in fair trade regions” while prioritizing profitability and raising prices. They referenced December preemptive pricing actions and an April price increase, claimed strong pricing execution, and noted flexible capacity adjustments (10%–20% capacity down earlier).

Sentiment: MIXED

Note: This summary was synthesized by AI from the CC Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — The Chemours Company (CC) Financial Profile